New Sepsis marker: PATHFAST Presepsin

Early prognosis of sepsis is key for improved clinical outcome

PATHFASTTM Presepsin is a chemiluminescent enzyme immunoassay for the quantitative measurement of presepsin concentration in whole blood or plasma. PATHFASTTM Presepsin can be used as an aid in the diagnosis and prognosis of sepsis, in the assessment of the degree of septic severity, and in the risk stratification of critically ill septic patients.